PEPG PepGen Corp Soliqdan keyingi foyda

PepGen Inc. (PEPG) kompaniyasining rasmiy ramzlari

PepGen Inc. dori vositalarining xavfsizligi bilan bog'liq qiyinchiliklarga va o'z platformasini rivojlantirish uchun keng ko'lamli kapitalga bo'lgan ehtiyojga duch kelmoqda. Kompaniyaning sof foyda tendentsiyasi ushbu jarayonlarni aniq namoyish etadi, bunda -0.07 belgisi ushbu parametrni xarakterlaydi. Geopolitik beqarorlik global eksportga to'sqinlik qilmoqda, biroq kuchli patent himoyasi distrofiya davolash sinovlari muvaffaqiyatli yakunlangach, potentsial monopoliyani ta'minlaydi.

Kompaniyaning sof foydasi: PepGen (PEPG) 28.04.2023 - 30.10.2026 uchun

pepgen.com (PEPG) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi PepGen|PEPG - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor bahosi PepGen Inc.|PEPG - Korxona qiymati
- emitentning balans qiymati statistikasi:
Bitta aksiya hisobiga sof aktivlar qiymati PepGen|PEPG - Kompaniyaning balans qiymati|Sof aktivlarga nisbatan bozor kapitallashuvi pepgen.com|PEPG - Kompaniyaning umumiy aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati PepGen Inc.|PEPG - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati PepGen|PEPG - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati PepGen Inc.|PEPG - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari PepGen|Oraliq qoplama koeffitsiyenti pepgen.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
PEPG - Kompaniyaning sof foydasi
Kompaniyaning asosiy tahlili:PepGen Corp
PepGen Inc. original mahsuloti

PGN-EDO51 dorisi orqali Dyushenn mushak distrofiyasi terapiyasini ishlab chiqish ulkan xarajatlarni talab qiladi, bu esa biotexnologiya ekotizimining hayotiy qobiliyatini baholashda sof foydani monitoring qilishni muhim qiladi. PepGen Inc. (PEPG) kompaniyasining haqiqiy foydasini tahlil qilish orqali investor barcha operatsion xarajatlar va soliqlarni chegirib tashlagandan keyingi yakuniy moliyaviy natijani aniqlaydi va risklarni minimallashtirish uchun fundamental aktivlarni tanlashda ushbu ko'rsatkichdan asosiy filtr sifatida foydalanadi.

Muhim raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|regencellbioscience.com - Soliqdan keyingi foyda|Sof foyda AXSM|ACAD - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|VKTX (Viking Therapeutics Corp) - Soliqdan keyingi foyda|Supernus Pharmaceuticals - Sof foyda|Yillik sof foyda catalystpharma.com (CPRX)|DNLI: Sof foyda|Kompaniyaning sof daromadi Harmony Biosciences Inc (HRMY)|Kompaniyaning sof foydasi Biohaven Pharmaceutical|Kompaniya foydasi AMLX (Amylyx Corp)|Sof daromad TRVI (Trevi Therapeutics)|PRAX (praxismedicines.com) - Yakuniy foyda|Sof foyda AVXL (Anavex Life Sciences Corp.)|Sof moliyaviy natija CeriBell Inc (CBLL)|PRTA - Kompaniyaning sof foydasi|ALEC (Alector, Inc.) - Kompaniya foydasi|ANNX: Sof foyda|Sof daromad Omeros|Sof daromad NGNE|AC Immune S.A. (ACIU) - Sof moliyaviy natija|Kompaniyaning sof foydasi Voyager Pharma (VYGR)|NMRA: Soliqdan keyingi foyda|Sof foyda SCLX (Scilex Holding Company)|tevogen.com (TVGN) - Kompaniyaning sof daromadi|ACOG - Kompaniyaning sof foydasi|Soliqdan keyingi foyda CGTX|IKT: Sof foyda|Yillik sof foyda Cassava Pharma SAVA|Kompaniyaning sof foydasi Assertio Holdings|Kompaniya foydasi COYA (Coya)|Sof foyda VTGN|OVID - Kompaniyaning sof daromadi|Acumen Pharma - Sof daromad|Sof foyda CervoMed Corporation CRVO|ATHE - Kompaniyaning sof foydasi|Yakuniy foyda CLNN (Clene Inc.)|Jupiter Neurosciences Inc (JUNS) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Relmada Therapeutics Inc (RLMD)|Kompaniyaning sof foydasi Annovis Bio Corp|Grace Tx - Soliqdan keyingi foyda|Sof foyda AIFF|KLTO - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi NeuroSense Therapeutics Ltd. NRSN|RVPH (Reviva Pharmaceuticals Holdings Inc.) - Soliqdan keyingi foyda|MetaVia, Inc. - Sof foyda|Yillik sof foyda NeurAxis Inc (NRXS)|HSDT: Sof foyda|Kompaniyaning sof daromadi Passage Bio (PASG)|Kompaniyaning sof foydasi Neuphoria Therapeutics, Inc.|Kompaniya foydasi NERV (Minerva Neurosciences Inc)|Sof daromad ATHA (Athira)|ADXN (Addex) - Yakuniy foyda|Sof foyda ALZN (Alzamend Neuro)|Sof moliyaviy natija Cyclerion Therapeutics Inc. (CYCN)|PTIX - Kompaniyaning sof foydasi|KTTA (Pasithea Therapeutics) - Kompaniya foydasi|CRGT: Sof foyda|Sof daromad Avenue Therapeutics Inc|Sof daromad BCLI|caratherapeutics.com (CARA) - Sof moliyaviy natija|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|ELYM: Soliqdan keyingi foyda|Sof foyda ITCI (Intra-Cellular Therapies, Inc.)|Longboard (LBPH) - Kompaniyaning sof daromadi|MRNS - Kompaniyaning sof foydasi|Soliqdan keyingi foyda NKGN|NRBO: Sof foyda|Yillik sof foyda Sage Therapeutics Inc. SAGE|Kompaniyaning sof foydasi Neurotrope|Kompaniya foydasi TRVN (Trevena Inc)|Sof foyda VIGL|WENA - Kompaniyaning sof daromadi|Cerevel Therapeutics, Inc. - Sof daromad